Anika Therapeutics Inc (NASDAQ:ANIK)

39.50
Delayed Data
As of May 23
 +0.55 / +1.41%
Today’s Change
30.91
Today|||52-Week Range
69.81
-26.73%
Year-to-Date

Today’s Trading

Previous close38.95
Today’s open38.84
Day’s range38.84 - 39.83
Volume188,572
Average volume (3 months)130,258
Market cap$560.0M
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-1.86%
Earnings growth (this year)-57.40%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+9.71%
P/E ratio30.9
Price/Sales7.16
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc+0.11+0.46%
LMNXLuminex Corp+0.06+0.22%
LMATLeMaitre Vascular In...+0.22+0.67%
XENTIntersect ENT Inc-0.15-0.38%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)$0.33
Annual revenue (last year)$113.4M
Annual profit (last year)$31.8M
Net profit margin28.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Joseph G. Darling
Chief Financial Officer, Secretary &
Treasurer
Sylvia Cheung
Corporate headquarters
Bedford, Massachusetts

Forecasts